D-Nome

About D-Nome

D-Nome is a health-tech startup utilizing cell-free synthetic biology to provide rapid and accurate molecular diagnostics. Their technology enables scalable diagnostic solutions, addressing the need for accessible and efficient testing in healthcare.

```xml <problem> Current molecular diagnostic methods often lack the speed, accuracy, and scalability needed for widespread and efficient testing, particularly in resource-limited settings. Traditional diagnostic techniques can be complex, time-consuming, and require specialized laboratory infrastructure. </problem> <solution> D-Nome is developing cell-free synthetic biology-based diagnostics to enable rapid and accurate molecular testing. Their technology aims to democratize molecular diagnostics by providing scalable solutions that can be deployed in various settings. The core technology, D-LAMP, is an enzyme mix that facilitates rapid and accurate diagnostic results. This approach simplifies the diagnostic process, potentially reducing the need for extensive laboratory equipment and skilled personnel. </solution> <features> - Cell-free synthetic biology platform for molecular diagnostics - D-LAMP enzyme mix for rapid and accurate results - Scalable diagnostic solutions suitable for diverse settings </features> <target_audience> The primary target audience includes healthcare providers, diagnostic kit manufacturers, and research institutions seeking accessible and efficient molecular diagnostic solutions. </target_audience> ```

What does D-Nome do?

D-Nome is a health-tech startup utilizing cell-free synthetic biology to provide rapid and accurate molecular diagnostics. Their technology enables scalable diagnostic solutions, addressing the need for accessible and efficient testing in healthcare.

Where is D-Nome located?

D-Nome is based in Hyderabad, Pakistan.

When was D-Nome founded?

D-Nome was founded in 2021.

How much funding has D-Nome raised?

D-Nome has raised 1555000.

Location
Hyderabad, Pakistan
Founded
2021
Funding
1555000
Employees
6 employees
Major Investors
Entrepreneur First, Ankur Capital, Campus Fund, Rebalance, Impact India Investment Partners

Find Investable Startups and Competitors

Search thousands of startups using natural language

D-Nome

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

D-Nome is a health-tech startup utilizing cell-free synthetic biology to provide rapid and accurate molecular diagnostics. Their technology enables scalable diagnostic solutions, addressing the need for accessible and efficient testing in healthcare.

dnome.in1K+
cb
Crunchbase
Founded 2021Hyderabad, Pakistan

Funding

$

Estimated Funding

$1M+

Major Investors

Entrepreneur First, Ankur Capital, Campus Fund, Rebalance, Impact India Investment Partners

Team (5+)

No team information available.

Company Description

Problem

Current molecular diagnostic methods often lack the speed, accuracy, and scalability needed for widespread and efficient testing, particularly in resource-limited settings. Traditional diagnostic techniques can be complex, time-consuming, and require specialized laboratory infrastructure.

Solution

D-Nome is developing cell-free synthetic biology-based diagnostics to enable rapid and accurate molecular testing. Their technology aims to democratize molecular diagnostics by providing scalable solutions that can be deployed in various settings. The core technology, D-LAMP, is an enzyme mix that facilitates rapid and accurate diagnostic results. This approach simplifies the diagnostic process, potentially reducing the need for extensive laboratory equipment and skilled personnel.

Features

Cell-free synthetic biology platform for molecular diagnostics

D-LAMP enzyme mix for rapid and accurate results

Scalable diagnostic solutions suitable for diverse settings

Target Audience

The primary target audience includes healthcare providers, diagnostic kit manufacturers, and research institutions seeking accessible and efficient molecular diagnostic solutions.

Want to add first party data to your startup here or get your entry removed? You can edit it yourself by logging in with your company domain.